Effect of golimumab induction therapy on histologic disease profile in patients with moderate to severe ulcerative colitis: Results from the randomised, placebo-controlled Phase 3 PURSUIT-SC trial-MedSci.cn

Effect of golimumab induction therapy on histologic disease profile in patients with moderate to severe ulcerative colitis: Results from the randomised, placebo-controlled Phase 3 PURSUIT-SC trial

Johansson, T; Weinstein, C; Meehan, A; Tzontcheva, A; Xu, P; Marano, C; de Hertogh, G

JOURNAL OF CROHNS & COLITIS, 2020; 14 (): S560

科室
- - 订阅+
  - 更多科室
工具
服务